Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer [Phase 1]
Phase 1 study of TKI 258 in combination with Xeloda (capecitabine) and oxaliplatin in advanced colorectal cancer and gastric cancer was term…
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Single-port Versus Conventional Laparoscopic Colorectal Surgery [Phase 1, Phase 2]
A Phase 1/2 clinical trial comparing single-port versus conventional laparoscopic colorectal surgery, sponsored by North Tees and Hartlepool…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: The Effect of a Virtual Navigator on Colorectal Cancer Patient Empowerment [NA]
A completed clinical trial evaluated whether a virtual navigator improves empowerment among colorectal cancer patients.
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating preoperative radiation therapy with capecitabine or fluorouracil, wi…
-
CLINICAL_TRIALS trial_result · 2016-03-18Clinical Trial Update: Impact of PET Scan on the Curative Strategy of Colo-rectal Cancers : A Randomized Study [NA]
A randomized study evaluating whether PET imaging changes the curative treatment strategy for colorectal cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases [Phase 1, Phase 2]
A Phase 1/2 study evaluating safety and feasibility of electrochemotherapy for unresectable colorectal cancer liver metastases; the trial st…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Observation of Patients With Metastatic Colorectal Cancer Starting Chemotherapy Combined With Bevacizumab (Avastin)
This clinical trial update reports results for patients with metastatic colorectal cancer treated with chemotherapy in combination with beva…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Adjuvant Aflibercept for Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial update of adjuvant aflibercept for metastatic colorectal cancer; study terminated with posted results.
-
FDA approval · 2016-03-09FDA Approved: ZALTRAP — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for ZALTRAP (ziv-aflibercept) with labeling changes expanding/ updating its approved use.
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Surgical Recovery After Left Lateral Hepatic Sectionectomy: Laparoscopic Versus Open Surgery. [NA]
A completed clinical trial comparing laparoscopic versus open left lateral hepatic sectionectomy for colorectal cancer with liver metastasis…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants [NA]
This is an update on a completed clinical trial comparing a genetic epidemiology risk assessment program to usual care in colorectal cancer …
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Prevalence of Colon Cancer in Pyogenic Liver Abscess
A completed clinical trial update evaluating the prevalence of colorectal cancer among patients with cryptogenic pyogenic liver abscess.
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins
A terminated clinical trial investigating interactions between platinum-based chemotherapy drugs (cisplatin, carboplatin, oxaliplatin) and p…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea [Phase 2]
A Phase 2 study evaluated glutamine as prophylaxis for irinotecan-induced diarrhea in metastatic colorectal cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated FluGlucoScan (18F-fluorodeoxyglucose) for cancer imaging in patients with cancer or suspected cancer; t…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal Cancer [Phase 2]
Phase 2 trial evaluating the efficacy of combining sorafenib with capecitabine in patients with advanced pre-treated colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer [Phase 3]
Phase 3 trial update of capecitabine (Xeloda) for metastatic colorectal cancer; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer [Phase 2]
Phase 2 trial evaluating oxaliplatin, capecitabine, and cetuximab with radiation therapy, followed by surgery, in patients with Stage II/III…
-
CLINICAL_TRIALS withdrawal · 2016-02-24Clinical Trial Update: A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin [Phase 2]
A Phase 2 trial evaluating whether glutamine can prevent oxaliplatin-induced neurotoxicity has been withdrawn; the update also includes a ph…
-
CLINICAL_TRIALS research · 2016-02-24Clinical Trial Update: The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer [Phase 2]
Phase 2 trial evaluating maintenance therapy with CIK cells plus S-1 and bevacizumab in patients with advanced colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy [Phase 2]
Phase 2 trial assessing a skin toxicity treatment in metastatic colorectal cancer patients treated with panitumumab plus irinotecan-based th…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer [Phase 2]
A Phase 2 clinical trial update evaluating a neoadjuvant triplet chemotherapy regimen for resectable colorectal cancer; the current status i…
-
FDA approval · 2016-02-18FDA Approved: CAPECITABINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for capecitabine filed by Teva Pharmaceuticals USA, Inc. (ANDA 091649).
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer [Phase 2]
A Phase 2 trial comparing Folfox4 plus weekly cetuximab versus Folfox4 plus biweekly cetuximab in metastatic colorectal cancer to assess saf…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Effect of Preoperative Chemoradiotherapy on Exercise Capacity as Measured by Cardiopulmonary Exercise Testing [NA]
This trial update examines whether preoperative chemoradiotherapy affects exercise capacity in colorectal cancer patients. Exercise capacity…